Amgen weight loss drug MariTide starts two phase three trials
The Amgen emblem is displayed exterior Amgen headquarters in Thousand Oaks, California, on Might 17, 2023. Amgen on Wednesday stated it has began two vital late-stage trials for its experimental weight reduction injection MariTide, one other step in its bid to enter the booming weight problems drug market. “We’re delighted to share that these trials…
